←Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer Early Detection, Hereditary Screening
Beth Karlan
MD
🏢UCLA David Geffen School of Medicine🌐USA
Professor of Obstetrics and Gynecology, Director Cancer Population Genetics
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Beth Karlan is a leader in hereditary ovarian cancer and has directed key biomarker and risk studies including GOG-0199. She has championed expanded BRCA testing in ovarian cancer patients. She directs cancer population genetics at UCLA.
Share:
🧪Research Fields 研究领域
BRCA testing
hereditary ovarian cancer
GOG-0199 biomarker
risk stratification
population genetics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Beth Karlan 的研究动态
Follow Beth Karlan's research updates
留下邮箱，当我们发布与 Beth Karlan（UCLA David Geffen School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment